ASUS VivoWatch ECG App Receives FDA Thailand Certification for Smart Health Monitoring

ASUS announced that the VivoWatch ECG app is now certified by the Food and Drug Administration Thailand (FDA Thai), a significant development for smart healthcare innovation in Thailand. This certification marks a milestone for ASUS, highlighting its growing role in the global digital health landscape and its dedication to medical-grade technology innovation.

Joe Hsieh, COO and Global Senior Vice President of ASUS, stated, 'Our goal is to provide individuals and healthcare providers with top health monitoring tools. This certification validates our technology and underscores ASUS's commitment to expanding global access to smart, medical-grade health solutions.'

The new ECG app allows users to measure their ECG readings directly through ASUS VivoWatch by placing a fingertip on the watch-face sensors for 30 seconds. Users can view the results and easily share them with their healthcare provider. The ECG functionality is available on ASUS VivoWatch 6 and ASUS VivoWatch 6 AERO models.

ASUS VivoWatch's ECG feature is suitable for individual consumers, hospitals, clinics, and other healthcare settings. It can be integrated into business-to-business (B2B) solutions to enhance VIP patient care and support premium health management services. In addition to ECG monitoring, ASUS VivoWatch also supports blood pressure monitoring, allowing users to track two essential cardiovascular indicators simultaneously.

The real-time data provided by VivoWatch helps detect potential health issues, making it a valuable tool for institutions looking to enhance care quality and operational efficiency. The ECG feature is available now.

According to the source: ASUS Pressroom.